| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/09/2006 | US20060030576 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| 02/09/2006 | US20060030573 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes |
| 02/09/2006 | US20060030561 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 02/09/2006 | US20060030560 Pyrimidine compounds |
| 02/09/2006 | US20060030557 Substituted pyridines having antiangiogenic activity |
| 02/09/2006 | US20060030540 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 02/09/2006 | US20060030045 Antisense modulation of c/ebp beta expression |
| 02/09/2006 | US20060030005 C3b/C4b complement receptor-like molecules and uses thereof |
| 02/09/2006 | US20060029669 Controlled release nateglimide formulation; reducing blood glucose concentration |
| 02/09/2006 | US20060029605 Use of ErbB receptor ligands in treating diabetes |
| 02/09/2006 | US20060029595 Methods of using human receptor protein 4-1BB |
| 02/09/2006 | DE69717294C5 Chinazolin derivate und diese enthaltende pharmazeutische zusammenstellungen Quinazoline derivatives and those containing pharmaceutical assortments |
| 02/09/2006 | DE10258007B4 Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel Aromatic Fluorglycosidderivate, pharmaceutical compositions containing them and methods for making these drugs |
| 02/09/2006 | DE102004034697A1 Mit Diphenylamin oder Diphenylaminderivaten substituierte Salicylthiazole, Verfahren zu deren Herstellung und deren Verwendung With diphenylamine or diphenylamine derivatives substituted Salicylthiazole, processes for their preparation and their use |
| 02/09/2006 | CA2784585A1 Glycogen or polysaccharide storage disease treatment method |
| 02/09/2006 | CA2784420A1 Glycogen or polysaccharide storage disease treatment method |
| 02/09/2006 | CA2587248A1 Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 02/09/2006 | CA2576103A1 The use of medicinal plants and extracts thereof for the well-being of animals in veterinary medicine and zootechnics |
| 02/09/2006 | CA2576093A1 Pharmaceutical compostion containing meltrin antagonist |
| 02/09/2006 | CA2576092A1 The use of medicinal plants and extracts thereof with growth promoting activity in veterinary medicine and zootechnics |
| 02/09/2006 | CA2576028A1 Heterocyclic compounds useful as dpp- iv inhibitors |
| 02/09/2006 | CA2576022A1 Composition for accelerating calcium absorption |
| 02/09/2006 | CA2575612A1 Methods of treating ccr2 mediated diseases or disorders |
| 02/09/2006 | CA2575339A1 Substituted n-acyl-2-aminothiazoles |
| 02/09/2006 | CA2575329A1 Indole, indazole or indoline derivatives |
| 02/09/2006 | CA2575100A1 Heterocyclic compounds |
| 02/09/2006 | CA2573198A1 Nicotinamide derivatives and their use as therapeutic agents |
| 02/09/2006 | CA2573000A1 Composition containing statins and omega-3 fatty acids |
| 02/09/2006 | CA2571937A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 02/09/2006 | CA2567795A1 Methods of treating type i diabetes by blocking vegf-mediated activity |
| 02/08/2006 | EP1623986A1 Use of vinca alkaloid and its salt |
| 02/08/2006 | EP1623984A1 Polymorphic form I of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/08/2006 | EP1623983A1 Heterocyclic compounds useful as DPP-IV inhibitors |
| 02/08/2006 | EP1623977A1 Intermediate compound which is used for the preparation of pioglitazone |
| 02/08/2006 | EP1623712A2 Selective estrogen receptor modulator in combination with dehydroepiandrosterone (DHEA) or analogues |
| 02/08/2006 | EP1623711A1 External patch containing estrogen and/or progestogen |
| 02/08/2006 | EP1623710A1 Receptor antagonist |
| 02/08/2006 | EP1623708A2 Pharmaceutical composition comprising acetyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism |
| 02/08/2006 | EP1623704A1 Therapeutic agent |
| 02/08/2006 | EP1623230A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39) |
| 02/08/2006 | EP1622909A1 Cannabinoid receptor ligands and uses thereof |
| 02/08/2006 | EP1622904A1 Cannabinoid receptor ligands and uses thereof |
| 02/08/2006 | EP1622903A1 Cannabinoid receptor ligands and uses thereof |
| 02/08/2006 | EP1622902A1 Cannabinoid receptor ligands and uses thereof |
| 02/08/2006 | EP1622899A1 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same |
| 02/08/2006 | EP1622897A1 Inhibitors of phosphatidylinositol 3-kinase |
| 02/08/2006 | EP1622886A2 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 02/08/2006 | EP1622618A1 Melanocortin receptor-specific compounds |
| 02/08/2006 | EP1622607A1 Angiotensin ii receptor blockers for preventing the development or progression of microvascular disease due to diabetes |
| 02/08/2006 | EP1622605A1 Use of phthalide derivatives for the treatment and prevention of diabetes mellitus |
| 02/08/2006 | EP1622600A1 Pharmaceutical formulation comprising anti-obesity agent and acidulant |
| 02/08/2006 | EP1478393A4 Anti-pathogen treatements |
| 02/08/2006 | EP1414463A4 Asymmetric synthesis of kavalactones |
| 02/08/2006 | EP1399138B1 Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate |
| 02/08/2006 | EP1358162B1 Dihydroindole and tetrahydroquinoline derivatives |
| 02/08/2006 | EP1119362B1 Use of tetracycline derivatives to enhance interleukin-10 production |
| 02/08/2006 | EP1112362B1 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 02/08/2006 | EP1109795B1 Thiazoline acid derivatives |
| 02/08/2006 | EP0687296B1 Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals |
| 02/08/2006 | CN1732251A Method for recovering phytosterol form by-product of vegetable oil refining |
| 02/08/2006 | CN1732154A Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| 02/08/2006 | CN1731992A Hypoestoxides, derivatives and agonists thereof for use in the treatment and prophylaxis of hyperlipidemia |
| 02/08/2006 | CN1731990A Nutritional composition for oral use |
| 02/08/2006 | CN1730083A Yuanhe tablet and process for preparing the same |
| 02/08/2006 | CN1730046A Medicinal composition for treating diabetes |
| 02/08/2006 | CN1730040A Buckwheat compound and method of obtaining the same for treatment of hyperglycemia |
| 02/08/2006 | CN1730009A Novel drug administering route of ginseng stem and leave general saponin and its preparation process and new indications |
| 02/08/2006 | CN1730002A Effervescence tablet preparation for replenishing nutritious elements to human being and its preparation method |
| 02/08/2006 | CN1729990A Dripping pills of diosgenin and its preparation process |
| 02/08/2006 | CN1729969A Flavone hippophaes drop pills and method for preparing the same |
| 02/08/2006 | CN1240718C Aggregates of human insulin derivatives |
| 02/08/2006 | CN1240716C Pituitary adenylate cyclase activated polypeptide derivatives and process for preparing the same |
| 02/08/2006 | CN1240709C Herminium's triochistisaponine extract and its extraction refining method and its medical use |
| 02/08/2006 | CN1240701C 2,3,4,4-tetrahydro-1H-pyrazino (1,2-a) quinoxalin-5(6H) one deivatives being 5HT2C agonists |
| 02/08/2006 | CN1240688C Quinazoline compounds |
| 02/08/2006 | CN1240433C Traditional Chinese medicine compositions for weight reduction |
| 02/08/2006 | CN1240422C Diabetes treating medicine powder |
| 02/08/2006 | CN1240421C Diabetes treating medicine |
| 02/08/2006 | CN1240417C Weight-reducing paster |
| 02/08/2006 | CN1240407C Chinese-medicinal extract with alpha-glucosidase inhibitor activity, and its preparing process and application |
| 02/08/2006 | CN1240406C Fatty-reducing paster |
| 02/08/2006 | CN1240399C Method for preparing silkworm powder and its use |
| 02/08/2006 | CN1240393C Application of astragalus root polysaccharide in preparation of antilipemic agent and health products |
| 02/08/2006 | CN1240391C Daidzein drip pill and its preparation method |
| 02/08/2006 | CN1240388C Selective estrogen receptor modulator in combination with dehydroepiandrosterone or its derivative |
| 02/08/2006 | CN1240379C Lipid peroxide-lowering compositions |
| 02/08/2006 | CN1240377C Stable pharmaceutical composition of pravastatin |
| 02/08/2006 | CN1240312C Body weight reducing health care product extracted from seaweed and its preparation method |
| 02/07/2006 | US6995272 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/07/2006 | US6995271 An intermediate to an antidiabetic compound, by reacting methyl (2-hydrocarbyl-5-methyloxazol-2-yl)acetate with sodium borohydride (NaBH4) using tetrahydrofuran as a solvent and methanol as activator; acetate becomes a 2-hydroxy ethyl group |
| 02/07/2006 | US6995269 Guanidinobenzamides |
| 02/07/2006 | US6995189 comprises fatty acids; for treatment/prevention of sepsis or inflammatory shock |
| 02/07/2006 | US6995184 Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors |
| 02/07/2006 | US6995182 1-sulfonyl pyrrolidine derivatives |
| 02/07/2006 | US6995171 Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents |
| 02/07/2006 | US6995159 4-piperazin-1-yl-2-(pyridin-2-ylmethoxy)-pyrimidine, 2-(6-methyl-pyridin-2-ylmethoxy)-4-piperazin-1-yl-pyrimidine, and 2-(6-chloro-pyridin-2-ylmethoxy)-4-piperazin-1-yl-pyrimidine; for treatment of seizure and eating disorders; reduced side effects |
| 02/07/2006 | US6995150 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 02/07/2006 | US6995147 Method of delaying the onset of diabetes |
| 02/07/2006 | US6995144 for example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 02/07/2006 | US6994970 Peptides which bind auto-antibodies for use in extracorporeal treatment; peptides bound to solid support for chromatography; specified amino acid sequence |